Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrence and Predictive OCT Biomarkers in Neovascular Age Related Macular Degeneration After Discontinuation of Anti-VEGF Therapy

NCT06717139 is registered in ClinicalTrials.gov with St. Erik Eye Hospital as lead sponsor.

NCT NCT06717139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrence and Predictive OCT Biomarkers in Neovascular Age Related Macular Degeneration After Discontinuation of Anti-VEGF Therapy
Lead sponsor
St. Erik Eye Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
March 9, 2023
Completion date
May 9, 2027
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration, neovascular (wet) age-related macular degeneration, retinal diseases